Trending now:  
ESC Heart Failure 2023 Highlights
Intravascular imaging-guided PCI shows better clinical outcomes than angiography-guided PCI
PORTICO NG study: Preliminary results with Navitor aortic valve are promising
Losing Sleep Over Weight Gain: Sleep Deficiency and Increased Visceral Obesity Risk
Revisiting the “Obesity-Survival Paradox” in Patients With Obesity and Heart Failure

Content for healthcare professionals only

Podcast |

Inflammation as predictor of future cardiovascular event risk

11 Apr 2023
Cardiology Update
Cardiology Update
Inflammation as predictor of future cardiovascular event risk
/

Both inflammation and hyperlipidemia contribute to cardiovascular disease. However in patients receiving statin therapy the relative contributions of inflammation and hyperlipidemia to future CV risk can change. As a result, this has implications on adjunctive therapy choice.

In this episode, Dr. Chadi Alraies discusses a recent study that evaluated high sensitivity CRP and LDL-C as predictors of cardiovascular event risk in patients on statin therapy.

For more cardiology research news join our newsletter or follow us on TwitterFacebookLinkedIn or Instagram

Original article: Ridker PM et al. Lancet. 2023 Mar 3;S0140-6736(23)00215-5.

Share: